Skip to content

Donor Funding: $75,000
Cancer Type: Blood cancers
Cancer Stage: Treatment
Funded in: 2018

Dr Timothy Hercus
University of South Australia

Cancer patients often have insufficient white blood cells and as a result are vulnerable to a range of fatal infections. Interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) are proteins that regulate the production and function of white blood cells that protect our body from infections but can have undesirable side-effects. Through understanding how IL-3 and GM-CSF function, we will develop selective variants that better stimulate white blood cell production.